{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:56:12Z","timestamp":1782266172656,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["81870876"],"award-info":[{"award-number":["81870876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China, China","doi-asserted-by":"crossref","award":["81470050"],"award-info":[{"award-number":["81470050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Municipal Natural Science Foundation, China","award":["7122097"],"award-info":[{"award-number":["7122097"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11064-019-02899-x","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T10:03:53Z","timestamp":1573034633000},"page":"2786-2795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism"],"prefix":"10.1007","volume":"44","author":[{"given":"Ding","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"2899_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, Treede RD (2011) A new definition of neuropathic pain. Pain 152:2204\u20132205","journal-title":"Pain"},{"key":"2899_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1470320314556171","volume":"16","author":"P Kaur","year":"2015","unstructured":"Kaur P, Muthuraman A, Kaur J (2015) Ameliorative potential of angiotensin-converting enzyme inhibitor (ramipril) on chronic constriction injury of sciatic nerve induced neuropathic pain in mice. J Renin Angiotensin Aldosterone Syst. 16:103\u2013112","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"2899_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","volume":"52","author":"JN Campbell","year":"2006","unstructured":"Campbell JN, Meyer RA (2006) Mechanisms of neuropathic pain. Neuron 52:77\u201392","journal-title":"Neuron"},{"key":"2899_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155:654\u2013662","journal-title":"Pain"},{"key":"2899_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3\u2013S14","journal-title":"Mayo Clin Proc"},{"key":"2899_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pain.2012.12.024","volume":"154","author":"A Pereira","year":"2013","unstructured":"Pereira A, Gitlin MJ, Gross RA, Posner K, Dworkin RH (2013) Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia. Pain 154:345\u2013349","journal-title":"Pain"},{"key":"2899_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O\u2019Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237\u2013251","journal-title":"Pain"},{"key":"2899_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuropharm.2010.10.019","volume":"60","author":"X Zhao","year":"2011","unstructured":"Zhao X, Ye J, Sun Q, Xiong Y, Li R, Jiang Y (2011) Antinociceptive effect of spirocyclopiperazinium salt compound LXM-15 via activating peripheral alpha7 nAChR and M4 mAChR in mice. Neuropharmacology 60:446\u2013452","journal-title":"Neuropharmacology"},{"key":"2899_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87\u2013107","journal-title":"Pain"},{"key":"2899_CR10","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers. 3:17002","journal-title":"Nat Rev Dis Primers."},{"key":"2899_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0149-2918(00)80043-0","volume":"22","author":"EV Hersh","year":"2000","unstructured":"Hersh EV, Moore PA, Ross GL (2000) Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 22:500\u2013548","journal-title":"Clin Ther"},{"key":"2899_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/0257-7941.122998","volume":"32","author":"US Paviaya","year":"2013","unstructured":"Paviaya US, Kumar P, Wanjari MM, Thenmozhi S, Balakrishnan BR (2013) Analgesic and anti-inflammatory activity of root bark of Grewia asiatica Linn. in rodents. Anc Sci Life. 32:150\u2013155","journal-title":"Anc Sci Life."},{"key":"2899_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bcp.2015.06.014","volume":"97","author":"M Quik","year":"2015","unstructured":"Quik M, Zhang D, McGregor M, Bordia T (2015) Alpha7 nicotinic receptors as therapeutic targets for Parkinson\u2019s disease. Biochem Pharmacol 97:399\u2013407","journal-title":"Biochem Pharmacol"},{"key":"2899_CR14","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00429-014-0762-4","volume":"220","author":"I Shelukhina","year":"2015","unstructured":"Shelukhina I, Paddenberg R, Kummer W, Tsetlin V (2015) Functional expression and axonal transport of alpha7 nAChRs by peptidergic nociceptors of rat dorsal root ganglion. Brain Struct Funct. 220:1885\u20131899","journal-title":"Brain Struct Funct."},{"key":"2899_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejphar.2015.11.056","volume":"770","author":"D Wan","year":"2016","unstructured":"Wan D, Wang D, Sun Q, Song Y, Jiang Y, Li R, Ye J (2016) Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting alpha7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKIIalpha\/CREB\/CGRP signaling pathway in mice. Eur J Pharmacol 770:92\u201398","journal-title":"Eur J Pharmacol"},{"key":"2899_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jpain.2008.01.336","volume":"9","author":"SJ Medhurst","year":"2008","unstructured":"Medhurst SJ, Hatcher JP, Hille CJ, Bingham S, Clayton NM, Billinton A, Chessell IP (2008) Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action. J Pain. 9:580\u2013587","journal-title":"J Pain."},{"key":"2899_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1074\/jbc.R000013200","volume":"276","author":"TR Soderling","year":"2001","unstructured":"Soderling TR, Chang B, Brickey D (2001) Cellular signaling through multifunctional Ca2+\/calmodulin-dependent protein kinase II. J Biol Chem 276:3719\u20133722","journal-title":"J Biol Chem"},{"key":"2899_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.expneurol.2004.11.010","volume":"192","author":"A Ogawa","year":"2005","unstructured":"Ogawa A, Dai Y, Yamanaka H, Iwata K, Niwa H, Noguchi K (2005) Ca(2\u2009+)\/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection. Exp Neurol 192:310\u2013319","journal-title":"Exp Neurol"},{"key":"2899_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2014.07.032","volume":"579","author":"M Boric","year":"2014","unstructured":"Boric M, Jelicic KA, Puljak L (2014) The expression of calcium\/calmodulin-dependent protein kinase II in the dorsal horns of rats with type 1 and type 2 diabetes. Neurosci Lett 579:151\u2013156","journal-title":"Neurosci Lett"},{"key":"2899_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12264-010-0933-0","volume":"26","author":"ML Guo","year":"2010","unstructured":"Guo ML, Mao LM, Wang JQ (2010) Modulation of M4 muscarinic acetylcholine receptors by interacting proteins. Neurosci Bull. 26:469\u2013473","journal-title":"Neurosci Bull."},{"key":"2899_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1124\/mol.62.5.1084","volume":"62","author":"A Duttaroy","year":"2002","unstructured":"Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, Wess J (2002) Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62:1084\u20131093","journal-title":"Mol Pharmacol"},{"key":"2899_CR22","first-page":"876","volume":"281","author":"MD Swedberg","year":"1997","unstructured":"Swedberg MD, Sheardown MJ, Sauerberg P, Olesen PH, Suzdak PD, Hansen KT, Bymaster FP, Ward JS, Mitch CH, Calligaro DO, Delapp NW, Shannon HE (1997) Butylthio[2.2.2] (NNC 11-1053\/LY297802): an orally active muscarinic agonist analgesic. J Pharmacol Exp Ther 281:876\u2013883","journal-title":"J Pharmacol Exp Ther"},{"key":"2899_CR23","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1213\/01.ane.0000287652.42309.5c","volume":"105","author":"JT Liou","year":"2007","unstructured":"Liou JT, Liu FC, Hsin ST, Yang CY, Lui PW (2007) Inhibition of the cyclic adenosine monophosphate pathway attenuates neuropathic pain and reduces phosphorylation of cyclic adenosine monophosphate response element-binding in the spinal cord after partial sciatic nerve ligation in rats. Anesth Analg 105:1830\u20131837","journal-title":"Anesth Analg"},{"key":"2899_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1152\/jn.00503.2005","volume":"95","author":"XJ Song","year":"2006","unstructured":"Song XJ, Wang ZB, Gan Q, Walters ET (2006) cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression. J Neurophysiol 95:479\u2013492","journal-title":"J Neurophysiol"},{"key":"2899_CR25","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1007\/s12035-015-9322-z","volume":"53","author":"CY Yao","year":"2016","unstructured":"Yao CY, Weng ZL, Zhang JC, Feng T, Lin Y, Yao S (2016) Interleukin-17A acts to maintain neuropathic pain through activation of CaMKII\/CREB signaling in spinal neurons. Mol Neurobiol 53:3914\u20133926","journal-title":"Mol Neurobiol"},{"key":"2899_CR26","doi-asserted-by":"publisher","first-page":"e92073","DOI":"10.1371\/journal.pone.0092073","volume":"9","author":"N Ogawa","year":"2014","unstructured":"Ogawa N, Kawai H, Terashima T, Kojima H, Oka K, Chan L, Maegawa H (2014) Gene therapy for neuropathic pain by silencing of TNF-alpha expression with lentiviral vectors targeting the dorsal root ganglion in mice. PLoS ONE 9:e92073","journal-title":"PLoS ONE"},{"key":"2899_CR27","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/jnr.23432","volume":"92","author":"P Andrade","year":"2014","unstructured":"Andrade P, Hoogland G, Del RJ, Steinbusch HW, Visser-Vandewalle V, Daemen MA (2014) Tumor necrosis factor-alpha inhibitors alleviation of experimentally induced neuropathic pain is associated with modulation of TNF receptor expression. J Neurosci Res 92:1490\u20131498","journal-title":"J Neurosci Res"},{"key":"2899_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0306-4522(03)00497-4","volume":"121","author":"W Ma","year":"2003","unstructured":"Ma W, Eisenach JC (2003) Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, calcitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience 121:681\u2013690","journal-title":"Neuroscience"},{"key":"2899_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.pain.2013.01.002","volume":"154","author":"S Hirsch","year":"2013","unstructured":"Hirsch S, Corradini L, Just S, Arndt K, Doods H (2013) The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats. Pain 154:700\u2013707","journal-title":"Pain"},{"key":"2899_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2015.05.005","volume":"271","author":"M Romero-Reyes","year":"2015","unstructured":"Romero-Reyes M, Pardi V, Akerman S (2015) A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: role of CGRP in orofacial pain. Exp Neurol 271:95\u2013103","journal-title":"Exp Neurol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02899-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02899-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02899-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:25:09Z","timestamp":1604535909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02899-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2899"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02899-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"26 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}